Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-17

FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Dr.Reddys Laboratories Inc)

View source ↗

Summary

FDA approved a supplemental application for a generic ezetimibe and simvastatin product from Dr. Reddy's Laboratories, authorizing its marketing. This represent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE AND SIMVASTATIN (ezetimibe and simvastatin)

Snippet

SUPPL AP for EZETIMIBE AND SIMVASTATIN (EZETIMIBE AND SIMVASTATIN)